Global Oxymetholone Powder Market is valued approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2023-2030. Oxymetholone Powder is a chemical substance that is used to treat muscle wasting disorders like AIDS by permitting muscle development even on a restricted diet. Oxymethalone powder, marketed under the trade name Andral, is a medicinal substance used to enhance body mass and cure anaemias induced by chemotherapy, such as aplastic anaemia, myelofibrosis, or hypoplastic anaemia. The rise in prevalence of anaemia and osteoporosis internationally, increased need for innovative oral medications, expansion in the biologics industry, technical developments, and development of new products such as synthetic male hormone are the factors driving the oxymetholone powder market.
Moreover, the growing geriatric population is anticipated to support the market growth. The anemia is commonly found in elderly individuals due to various factors such as chronic diseases, nutritional deficiencies, and age-related decline in the production of red blood cells. With the global aging population, the demand for Oxymetholone powder for the treatment of anemia in the elderly could increase. According to the World Bank, 8% of the total population aged 65 and older lived in the world in 2015, and in 2021 the rate reached 10 %. Additionally, the introduction of these pharmaceuticals for the treatment of various ailments such as HIV, primarily in developing nations, as well as increased awareness among various healthcare institutions, present multiple potential for market expansion. However, Stringent government regulatory requirements for this drug’s approval, as well as accompanying adverse effects when used in big dosages, limit market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Oxymetholone Powder Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increased need for dietary supplements, health care, and personal care goods. Furthermore, the rising prevalence of chronic disorders is fueling the expansion of this market. Asia Pacific is expected to grow significantly during the forecast period, owing to growing product demand due to uses in nutritional supplements, and growing demand in healthcare, and personal care.
Major market player included in this report are:
Heroids Pharmaceutical Co. Ltd.
Hongkong WinstonChem Technology Co., Ltd.
Belco Pharma
Euphoria Healthcare Pvt. Ltd.
Zhuhai Wumei Technology Co., Ltd.
Syntex Pharmaceuticals
Astra Zeneca
Carbone Scientific Co., Ltd.
Kinbester Co., Ltd.
Clarlab Co., Ltd.
Recent Developments in the Market:
NA
Global Oxymetholone Powder Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Application, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Dietary Supplement
Patient Care
Personal Care
Disease Treatment
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa